SOSV is a global venture capital firm based in Princeton, New Jersey, founded in 1995, that focuses on seed to growth investments in deep technology across health, environmental tech, hardware, robotics, and cross border software, with a particular emphasis on Asia. The company runs accelerator style startup development programs, including HAX and IndieBio, which provide facilities, engineering resources, and lab equipment to help founders accelerate product development, acquire customers, and attract later stage funding. SOSV pursues a limited number of high potential startups, offering extensive hands on support to speed commercialization and scale, and aims to back innovations that improve human and planetary health.

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

Khosla Ventures is a California-based venture capital firm founded in 2004 by Vinod Khosla. The firm backs entrepreneurs with venture assistance, strategic guidance, and capital, focusing on bold, early-stage technology companies. It invests across sectors including AI, climate and sustainability, enterprise software, consumer technologies, fintech, digital health, medtech and diagnostics, therapeutics, and frontier technologies. Based in Menlo Park, the firm manages several funds to support startups across stages, prioritizing ventures that address large markets and have potential for significant social and economic impact.

Qiming Venture Partners is a China-based venture capital firm founded in 2006, with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages USD and RMB funds totaling about 9.5 billion in capital and backs early- and growth-stage technology, consumer, and healthcare companies. The firm has backed more than 530 portfolio companies, with over 200 exits via IPOs or M&A, and more than 70 unicorn or super unicorn companies.

Alumni Ventures Group is a venture capital firm based in Manchester, New Hampshire, established in 2013. It targets individual accredited investors who previously had limited access to venture capital by enabling alumni from top entrepreneurial schools to invest together in ventures led by fellow alumni. The firm backs companies with an alumni connection and an institutional lead investor with sector expertise. It offers focused funds that provide accredited investors access to a diversified venture portfolio by type, sector, stage, and geography. The organization engages in seed, early-stage, and late-stage pre-IPO investments across technology, consumer, financial services, health care, life sciences, and other sectors.

Antler is a global venture capital firm based in Singapore that backs early-stage technology companies. It runs incubation programs and provides a global community of co-founders, access to talent, expert advisors, expansion support, and capital to help startups grow. The firm targets a broad range of sectors, including healthcare, finance, software, energy, consumer and B2B technologies, and operates through regional programs across Europe, the United States, the United Kingdom, Southeast Asia, India, Africa, and beyond.

Samsung Electronics is a global technology company based in South Korea that designs, manufactures, and sells a wide range of electronics and device solutions. Its portfolio spans consumer electronics (mobile devices, televisions, home appliances, cameras), information technology products (PCs, peripherals, printers), semiconductors, memory and storage, and display technologies. The company also provides telecommunications infrastructure and related services, and conducts extensive research and development to advance core technologies. With a global footprint across Korea, China, the Americas, Europe, and the Asia Pacific, Samsung Electronics is a leading supplier of smartphones, memory chips, and displays, and it coordinates significant manufacturing and supply chain activities to support its varied product lines.

High-Tech Gründerfonds is a Germany-based seed and early-stage venture capital firm focused on technology companies in Germany. Based in Bonn with an additional office in Berlin, it operates as a public-private partnership that supports high-tech startups across information technology, software, hardware, life sciences, chemistry and related fields. HTGF provides initial funding and follow-on capital to eligible young companies, often taking minority stakes and participating as lead or co-investor, while offering hands-on guidance from experienced investment managers and startup experts. Since its founding in 2005, the firm has backed numerous startups and facilitated the growth of portfolio companies through multiple funds aimed at early stages. The model combines both public support, involving government and financial institutions, with private investor participation to nurture startups from concept to market.

General Catalyst is a venture capital firm founded in 2000 that provides early-stage and growth equity investments in technology companies. It supports portfolio companies with momentum and mentorship to accelerate growth toward long-term success and typically engages across seed to growth stages, potentially taking minority or majority stakes. The firm targets a broad range of sectors enabled by software and technology, including consumer, enterprise, fintech, crypto, healthcare IT, and related areas, and maintains a multi-region presence with offices in North America and Europe to back companies as they scale globally.

Right Side Capital Management is a San Francisco-based venture capital firm founded in 2010 that invests in early-stage technology startups. It specializes in pre-seed and seed rounds for capital-efficient companies, with a focus on the United States and Canada and occasional activity in Western Europe, Israel, Australia, and New Zealand. The firm typically makes 75 to 100 investments per year, with round sizes from 50,000 to 500,000 and pre-money valuations ranging from 1,000,000 to 3,500,000. Portfolio companies are typically located outside the San Francisco Bay Area and New York City, and the firm aims to provide a clear yes or no on opportunities within about two weeks.

Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, Maryland, with additional offices in San Francisco and Cambridge. Founded in 2018, the firm invests in life sciences and technology companies across biotechnology, diagnostics, digital health, environmental technologies, and related industries, including AI and machine learning-enabled therapeutics and medical technologies. It targets growth capital and early-stage opportunities, providing capital and strategic support to help scientific innovations reach the market. The firm operates as a registered investment adviser.

Morningside is a Boston-based investment firm founded in 1986 as a family office for the Chan family. It makes venture capital investments in companies with novel science and technology, with deep expertise in life sciences, digital health, artificial intelligence, materials, and technology. The firm takes a long-term approach to building companies and emphasizes ethical conduct. In addition to its investment activities, Morningside supports charitable initiatives in education, research and healthcare, including collaborations with Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

SFC Capital is a United Kingdom-based venture capital firm founded in 2012 that makes early-stage investments in UK startups, including pre-seed and seed rounds. It backs companies across sectors such as software, technology, e-commerce, consumer, enterprise, green tech, medical technology, and hospitality, providing capital plus strategic guidance to support growth and product development. The firm operates a model that combines an angel network with seed funds to back SEIS- and EIS-qualifying businesses, aiming to offer exposure to a diversified portfolio while delivering hands-on support to portfolio companies.

StartUp Health is a health innovation platform founded in 2011 that supports a global portfolio of health technology companies through a network of entrepreneurs known as Health Transformers. Its mission is to achieve health moonshots by advancing solutions across Access to Care, Cost to Zero, Cure Disease, End to Cancer, Women’s Health, Children’s Health, Nutrition and Fitness, Brain Health, Mental Health and Happiness, Addiction, Longevity, and Pandemic Response. The organization oversees more than 330 portfolio companies across six continents and 26 countries, working with leading health systems and investors to accelerate adoption and impact. By connecting entrepreneurs with health systems, researchers, and investors, StartUp Health aims to improve the health and wellbeing of people worldwide and transform healthcare delivery over a multi-decade timeframe.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a non-profit organization founded in 1982 that supports the region's technology ecosystem. Based in Philadelphia, it acts as a capital provider and catalyst for early-stage and growing technology companies across information technology, health, and physical sciences by offering seed-stage funding and related resources to accelerate commercialization. The organization facilitates university–industry partnerships and regional initiatives that connect scientific research with market opportunities, with the aim of creating jobs and strengthening entrepreneurial communities in Southeastern Pennsylvania. Through its programs and partnerships, it supports adoption of new technologies and helps build a robust regional innovation ecosystem.

Founders Fund is a San Francisco-based venture capital firm that backs science and technology companies across stages. The firm focuses on transformational technologies and has supported early backers of SpaceX, Palantir, Facebook, and Airbnb. It pursues a founder-friendly approach that provides significant support with minimal interference, and it invests globally across sectors including software, artificial intelligence, aerospace, energy, healthcare, cybersecurity, biotech, and information technology. The firm targets opportunities from seed to growth stages and emphasizes solving difficult problems through innovative technology.

OrbiMed is a healthcare-focused investment firm based in New York, founded in 1989, with approximately $5 billion in assets under management. It engages in private equity, venture capital, and growth investments across the global healthcare landscape, spanning biopharmaceuticals, biotechnology, life sciences tools, medical devices, diagnostics, health care services, and digital health. The firm invests across the development spectrum, from startup ventures to mature companies, and pursues opportunities worldwide, including North America, Europe, Asia, Israel and India, leveraging a long-standing specialization in the sector. Through its diversified capital programs, OrbiMed partners with management to advance innovative therapies, tools, and services that address significant medical needs.

Keiretsu Forum is an international investment community of accredited private equity investors, venture capitalists and corporate/institutional investors. Founded in San Francisco in 2000, it operates as a worldwide network that structures access to high-quality deal flow and investment opportunities through regional chapters across the United States, Europe and Asia. It is described as the world’s largest invitation-only angel investor network, with thousands of investor members who participate in funding opportunities for early- to growth-stage companies in technology, healthcare, energy, consumer products and other sectors. The forum emphasizes collaboration among members and partner resources to support due diligence, syndication and capital deployment, enabling private capital to back high-potential ventures.

Eli Lilly is a global pharmaceutical company that discovers, develops, manufactures, and sells medicines across neuroscience, cardiometabolic diseases, cancer, and immunology. It operates manufacturing and research facilities in the United States, Puerto Rico, and about 25 other countries, with products sold in roughly 135 countries. The portfolio includes Verzenio, Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, Humulin, Taltz, and Olumiant, reflecting a diversified, science‑driven approach. In addition to human medicines, Lilly conducts research in animal health to treat animal diseases and support agricultural productivity. The company maintains a strong emphasis on research and development to address unmet medical needs and to bring innovative therapies to patients worldwide.

Mayo Clinic is a non-profit medical organization based in Rochester, Minnesota, established in 1863. It provides comprehensive medical care, education in clinical medicine and biomedical sciences, and conducts extensive medical research across a broad range of specialties. The organization integrates patient care with education and research to advance medical practice and outcomes. It also advances innovation through Mayo Clinic Platform, a Rochester-based accelerator that incubates and invests in early-stage health-tech startups in collaboration with providers, pharmaceutical and device companies, health-tech developers, and patients; and Mayo Clinic Ventures, the organization's venture arm that partners with physicians and scientists to commercialize inventions and discoveries to improve patient care and support Mayo’s education and research missions.

IMM Investment is a Seoul-based independent private equity and venture capital firm established in 1999. The company engages in mezzanine and growth investments and pursues opportunities in mergers and acquisitions, venture capital, corporate restructuring, private equity, industry consolidation, management buyouts, spin-offs, recapitalizations, and cross-border transactions. It concentrates on medium-sized companies operating in information technology infrastructure, wireless communications, software, contents, and other technology-enabled sectors, with a particular emphasis on information technology, healthcare/biotech, and manufacturing. The firm typically takes an active role in governance and strategic direction and focuses on opportunities within South Korea and cross-border contexts. IMM Investment aims to support portfolio companies through growth, expansion, and consolidation, leveraging its long-standing relationships with institutional investors and investment professionals.

Deerfield Management is a New York-based investment management firm founded in 1994 that focuses on healthcare. It engages in long-term structured investments in both public and private healthcare companies, and operates across investment activities, information services, and philanthropy. It acts as an investment adviser and supports private and public investments across life sciences, medical devices, diagnostics, digital health, and health services.

IP Group is a London-based venture capital firm that focuses on commercialising intellectual property from research-intensive institutions. It creates value by identifying early-stage IP, developing it into commercially viable opportunities, and forming strategic partnerships to support portfolio companies. The firm provides capital, strategic guidance, and industry insight to science- and technology-based businesses, with emphasis on clean technology, life sciences, and deep tech. With more than twenty years of experience, IP Group supports the growth of science and technology companies from inception toward scale, helping translate research into market-ready products and accelerate their impact.

European Investment Fund (EIF) is a public institution established in 1994 to improve access to finance for Europe's small and medium-sized businesses. It designs and develops venture capital and guarantee instruments to support SMEs and to catalyse private investment, aiming to build a robust European equity ecosystem. EIF engages in venture capital, growth capital, and guarantee operations, backing innovative entrepreneurs primarily in technology and life sciences, as well as across other sectors. Through cornerstone investments and fund participation, EIF seeks to crowd in private investors and stimulate venture activity across Europe. Its equity portfolio has grown substantially, with assets under management exceeding EUR 14 billion, reflecting its broad role in strengthening SME finance and supporting entrepreneurship and growth.

Kurma Partners is a Paris-based investment management company focused on funding innovation in healthcare and biotechnology across Europe. Established in 2009, it targets early-stage to development capital for life sciences companies and digital health ventures, spanning healthcare, biotechnology, and related technology sectors. The firm pursues a hands-on approach to support research-driven startups, leveraging connections with research institutes and hospitals to advance therapeutic and medical innovations. Through its activity as a private equity and venture investor, Kurma Partners seeks to back companies throughout their growth trajectory, from initial concept to market readiness, helping them navigate clinical development, regulatory pathways, and commercialization in the European market.

Legend Capital is a Beijing-based venture capital firm and the investment arm of Legend Holdings, established in 2001 to become a leading venture capital manager in China. It manages up to about US$700 million across four funds and focuses on high-growth ventures with operations in China or markets related to China, particularly in early-stage information technology including network applications and services, outsourcing and professional services, and infrastructure components such as IC design, as well as mid-market growth in consumer goods, clean technology, healthcare, equipment manufacturing, and modern services. As an active investor, Legend Capital provides portfolio companies with strategic resources, business development support, and market guidance to help them scale in the Chinese market. Notable investments include Joyo.com, SinoCom, Solarfun Power, Spreadtrum Communications, China Sunshine Paper, and VanceInfo, among others.

Innovation Works is a Pittsburgh-based venture capital firm established in 1999 that targets seed-stage technology companies in Southwestern Pennsylvania. It provides capital, business guidance, and other resources to high-potential startups and is the region's largest seed-stage investor. The organization also helps manufacturers adopt new technologies and pursues investments in robotics, artificial intelligence, medical devices, retail technologies, and enterprise software.

Gaingels is a venture investment organization focused on LGBTQ+-founded and led companies and their allies, investing across stages from pre-seed to pre-IPO and maintaining a global portfolio. Founded in 2014 and based in New York, it operates as a syndicate with more than 130 portfolio companies and around $70 million deployed. The organization supports inclusive leadership by backing ventures that promote diverse C-suite and board representation and actively assists portfolio companies in recruiting diverse executive talent. It also fosters a global community of industry leaders, investors, operators, and entrepreneurs who pursue positive social change through business and successful investments.

ARCH Venture Partners is a United States-based venture capital firm founded in 1986 and headquartered in Chicago, Illinois. The firm focuses on science-driven companies, with a track record of commercializing technologies developed at academic research institutions and national laboratories. It primarily invests in life sciences, biotechnology, pharmaceuticals, healthcare technology, and related sectors, and also backs software, materials, clean tech, and information technology across early to growth stages. ARCH emphasizes relationships with scientists and entrepreneurs, often taking early stakes and supporting subsequent rounds to help market entry and scale. The firm has raised multiple venture funds totaling several billion dollars and maintains a national and international reach with offices across North America.

Parkwalk Advisors is a London-based venture capital firm that focuses on investing in early-stage to growth-stage technology companies, with a particular emphasis on spin-outs derived from UK universities and research institutes. It targets UK-based, often unquoted companies across sectors such as artificial intelligence, big data, life sciences, materials, cleantech, future mobility, medical technology, quantum computing and related fields, and operates with a stage-agnostic approach from seed through later rounds. The firm leverages academic networks, technology transfer channels and venture networks to access deal flow and support portfolio companies. Founded in 2009, it has been aligned with IP Group as part of its corporate structure, reinforcing its focus on intellectual property-backed innovation. The company is headquartered in London, United Kingdom.

RA Capital Management is a Boston-based investment firm that specializes in life sciences and healthcare companies. The firm provides investment management and venture capital services, backing companies developing drugs, medical devices, diagnostics, and biotech tools. Its team combines expertise in biology, chemistry, and medicine with industry and business development experience. RA Capital supports companies across multiple stages, from seed funding to growth financings, including private and public rounds, and often takes board seats and seeks co-investment opportunities. Through its activity, it aims to identify technologies with potential to advance prevention and treatment, genetic testing and personalized medicine, and other patient-focused innovations.

BioVenture, established in September 2013, specializes in early-stage venture capital investments in the field of life sciences, focusing on biotechnology, drug discovery, medical devices, and healthcare services companies. With a fund size of 540 million yuan, BioVenture provides capital and post-investment support to innovative companies with high growth potential. Backed by Suzhou Industrial Park and BioBay, BioVenture aims to become one of China's most successful medical and pharmaceutical venture funds by leveraging its industry expertise and resources. The team at BioVenture consists of senior investment professionals with deep knowledge of domestic and foreign markets, aiming to help companies grow rapidly and achieve greater success while delivering considerable returns to fund investors. Through joint venture development cooperation, BioVenture seeks to drive innovation and growth in the medical and pharmaceutical industry.

eHealth Ventures is a Tel Aviv-based venture capital firm and incubator-focused consortium that provides incubation services to promising early-stage healthcare technology companies in Israel. It backs digital health ventures, focusing on digital therapeutics and diagnostics, and builds and invests through partnerships with two venture funds and a technology incubator, leveraging substantial government non-dilutive funding in Israel's incubator ecosystem.

Entrepreneur First is a London-based accelerator and seed-stage technology investor that supports exceptional individuals to found technology companies. It uses a talent-first model, funding and mentoring people before teams form, and operates six-month programs in Europe and Asia with global offices in London, Paris, Berlin, Singapore, Bangalore, New York and San Francisco to connect founders with startup ecosystems. The organization funds early-stage ventures and takes an equity stake in the companies it helps establish, aiming to increase the supply of high-potential tech startups worldwide by pairing standout talent with mentorship and capital.

WI Harper Group is a San Francisco-based venture capital firm with a China-focused footprint, including offices in Beijing and Taipei. Founded in 1993, it invests in startup companies across the United States, Greater China, and the Asia Pacific in sectors such as healthcare, biotechnology, artificial intelligence, robotics, fintech, sustainability, and new media. The firm targets early and expansion-stage opportunities, supporting companies from seed to later rounds and helping bridge U.S. and Greater China markets through cross-border expertise.

Polaris Partners is a Boston-based venture capital firm with offices in Boston and San Francisco that backs technology and life sciences companies across the United States and Europe. Founded in 1996, the firm partners with repeat entrepreneurs to support companies through multiple stages, from inception to growth, with a focus on software, healthcare information technology, digital health, life sciences, biotechnology, pharmaceuticals, genomics, and related sectors. Its investments span the business-to-business and business-to-consumer markets, software as a service, and other technology-enabled solutions, aiming to build durable platform companies and address significant needs in healthcare and technology.

HealthTech Capital is a private investor group that funds and mentors healthtech startups at the intersection of healthcare, computing, and mobility. The group aims to foster an ecosystem by connecting clinical providers, venture firms, and other strategic industry players to support healthtech innovation. Founded in 2010 and based in Los Altos Hills, California, it operates as an angel group investing in healthtech startups.

Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities. It provides seed through growth capital to life science and technology companies developing breakthrough therapies, diagnostics, research tools, agrifoodtech, agtech, digital health, and related platforms. Backed by the parent company’s industry experience and scientific advisory network, the firm leverages long-standing relationships and domain expertise to support early to growth-stage ventures aiming to translate scientific advances into practical healthcare and technology solutions.

Sand Hill Angels is a Mountain View, California-based angel investor network in Silicon Valley founded in 2000. The group comprises around 60+ technology professionals who collaborate to form and grow startup companies by investing in private technology firms at early stages. Its members focus on technology sectors including clean technology, Internet, information sciences, and life sciences, with activity in areas such as semiconductors, enterprise software, storage, and communications, as well as medical devices, diagnostics, and bioinformatics. Sand Hill Angels typically invest in seed and Series A rounds, and occasionally later-stage bridges, often committing $300K to $500K at a pre-money valuation under $5 million. The network works openly with venture capital funds and other angel groups to support the Bay Area ecosystem.

New Enterprise Associates is a U.S.-based venture capital firm founded in 1977 and headquartered in Menlo Park, California. It invests in technology and healthcare companies across stages and geographies, supporting startups from seed to growth. The firm operates globally with investments in the United States, Asia, and Brazil among others, and has a long track record of portfolio IPOs and acquisitions. It has over $19 billion in cumulative committed capital.

Matrix Partners is a San Francisco-based venture capital firm founded in 1977 that backs technology companies from idea through Series A and beyond. The firm focuses on software, AI, B2B, consumer, fintech, health tech, infrastructure, and related sectors, with a global footprint in the United States, India, and China. Its team comprises former founders and operators who work closely with portfolio companies and often join boards to support growth. Matrix Partners has backed a broad slate of successful companies in its decades-long history, including Apple, FedEx, Oculus, Zendesk, HubSpot, Canva, and Postmates, illustrating a pattern of helping developers and builders scale toward IPO or strategic exits. The firm's China arm extends its early-stage and growth investments in the Chinese market, reinforcing its international reach.

Felicis Ventures is a Menlo Park, California-based venture capital firm that backs founders building iconic, boundary-transcending companies. It focuses on early-stage investments across software, information technology, consumer internet, AI, health, and security, and complements capital with active mentoring and advisory support. The firm pursues global opportunities, maintains a diverse portfolio, and has backed over 120 technology companies, with around 50 exits. It was founded by Aydin Senkut, a former Google executive, and emphasizes reinvention of core markets and frontier technologies.

Accel is a venture capital firm founded in 1983 by Arthur Patterson and Jim Swartz and headquartered in Palo Alto, California, with additional offices in San Francisco, London and Bangalore. It funds early- and growth-stage technology companies across software, cloud, SaaS, consumer, enterprise IT and related sectors, and it supports portfolio companies as they scale internationally. With a global network and more than three decades of experience, Accel seeks to help entrepreneurs build world-class, category-defining businesses. Notable investments include Atlassian, Facebook, Dropbox, Slack, Spotify, Etsy, Braintree, Cloudera and Qualtrics, among others. Accel operates multiple funds and programs to back companies at different stages, continuing a long track record of backing ambitious technology founders around the world.

Par Equity is a venture capital and private equity firm backed by Scottish Enterprise, based in Edinburgh with an office in San Francisco. It specializes in early‑stage and growth investments in technology companies, including software, deep tech and digital health, targeting opportunities in Scotland, Northern England and Northern Ireland, with cross‑border expansion between the United Kingdom and the United States. The firm funds proprietary technology and proven products poised for international growth, supporting UK companies expanding to the United States and US entrants seeking a UK presence. Typical investments range from £0.25 million to £2.5 million, with enterprise values up to about £10 million. It also provides angel capital to investee companies and focuses on cross‑border deals to accelerate scale.

Shenzhen Capital Group is a government-backed venture capital firm established by the Shenzhen Government in 1999. It focuses on cultivating national industries and brands, promoting economic transformation, and developing emerging sectors. The firm invests primarily in small to medium-sized enterprises and innovative high-tech companies across start-up, growth, and transformation stages, targeting industries aligned with national policies such as information technology, internet and new media, biopharma, new energy, environmental protection, chemical engineering, new materials, high-end equipment manufacturing, consumer goods, and modern services. Through its portfolio, it aims to build national champions and support industrial upgrading in China, leveraging its capital base to support long-term value creation.

Korea Investment Partners is a Seoul-based venture capital and private equity firm with decades of experience in funding bold, innovative entrepreneurs. It operates globally with offices in Shanghai, Beijing, and Sunnyvale and manages multiple funds totaling several billions of dollars in assets under management. As the venture capital and private equity arm of Korea Investment Holdings, KIP backs a broad range of sectors including information technology, healthcare, life sciences, manufacturing, mobility and gaming, as it seeks to help companies scale and commercialize new technologies. The firm emphasizes long-term value creation and has built a diversified portfolio across Asia and beyond.

What If Ventures is a venture capital firm based in Frisco, Texas, that backs startups in healthcare and aerospace and defense. Founded by Stephen Hays around 2019–2020, the firm targets early-stage companies from seed to Series C and has deployed nearly $100 million across more than 80 healthcare startups. Hays' background as a U.S. Army veteran and West Point graduate, with prior experience in aerospace and defense investment banking, informs a focus on large, fragmented markets with complex regulation and significant government and commercial customers. The firm seeks to fund disruptive innovations that can improve lives or enhance safety, tackling industries where new entrants historically struggle to gain traction against established incumbents.

MassVentures is a Massachusetts-based venture capital firm that provides seed and early-stage funding to high-growth startups in the Massachusetts innovation economy, helping concepts move from idea to commercialization. Founded in 1978 as a quasi-public corporation by the Legislature of the Commonwealth, it is governed by an independent board and managed by experienced venture investors. The firm focuses on information technology, healthcare, cybersecurity, e-commerce, mobile, manufacturing, and robotics sectors in Massachusetts and operates accelerator programs to support portfolio companies. MassVentures leverages the state's entrepreneurial ecosystem, educated workforce, and centers of innovation to back early-stage ventures.

Liquid 2 Ventures is a San Francisco, California-based venture capital firm that provides seed-stage and early-stage investments to technology startups. Founded in 2015 by Joe Montana, Mike Miller, and Michael Ma, the firm focuses on technology companies across software, telecommunications, media, and other TMT sectors, offering early funding and strategic guidance to its portfolio companies.

IDG Capital is a global investment firm that backs technology-focused companies across stages, from early to growth. With a blend of international reach and local market insight, the firm mobilizes resources to help portfolio companies scale in China, Asia, and beyond. It partners with private equity and venture capital fund managers and other investment entities, drawing on a broad base of limited partners including sovereign wealth funds, pension funds, institutions, and family offices. The team combines deep local knowledge with global perspectives to identify opportunities and provide strategic support, governance, and access to networks that accelerate growth. IDG Capital targets software, information technology, consumer and healthcare sectors, among others, and pursues a long-term value strategy through active collaboration with management teams and ecosystem players rather than short-term financing alone.